SS

Sonalkumari Sunilbhai Patel

Active Director Designated Partner DIN 11657932
DIN 11657932 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sonalkumari Sunilbhai Patel

Data last updated:

Sonalkumari Sunilbhai Patel is a Designated Partner at Prayosha Lifesciences Llp (since 2026).

DIN 11657932
Primary Designation Designated Partner
First Appointment 10 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Apr 20262026Active

Board colleagues of Sonalkumari Sunilbhai Patel

NameDINCompanyDesignation
Nayanaben Rajubhai Thanth11657934Prayosha Lifesciences LlpDesignated Partner
Paresh Kalubhai Bharodiya11657933Prayosha Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Prayosha Lifesciences Llp
Premium access

Shareholding and investment profile for Sonalkumari Sunilbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonalkumari Sunilbhai Patel

Sonalkumari Sunilbhai Patel currently holds 1 directorship: Prayosha Lifesciences Llp (Designated Partner, since 10 Apr 2026).

Sonalkumari Sunilbhai Patel was first appointed on 10 Apr 2026 as Designated Partner at Prayosha Lifesciences Llp.

The current boards of Sonalkumari Sunilbhai Patel's companies include Nayanaben Rajubhai Thanth (Prayosha Lifesciences Llp), Paresh Kalubhai Bharodiya (Prayosha Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available